Cardiovascular Risk Associated with Polypharmacy in Heart Failure: A Systematic Review and Meta-Analysis
Polypharmacy in patients with HF was associated with increased risk of composite CV outcome and HF hospitalization, reflecting the complexity of managing multiple medications. These findings underscore the need for individualized medication reviews to minimize inappropriate prescribing and ensure continued delivery of evidence-based therapies.
Authors
- Minseo Kim (ORCID: https://orcid.org/0009-0001-9279-1289)
- Sunny Kumar
- Gerald Chi
- Jane J Lee
Institutions
- Beth Israel Deaconess Medical Center (US)
- Sookmyung Women's University (KR)
- United Health Services (US)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1093/eschf/xvag005
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00